Skip to content

IQV

IQVIA Holdings Inc.

NYSE · Healthcare · Medical - Diagnostics & Research · US

$266.63
−1.84%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue17.0B16.3B15.4B15.0B14.4B
Cost of Revenue12.5B12.0B10.0B9.7B9.4B
Gross Profit4.5B4.3B5.4B5.2B5.0B
Operating Expenses
R&D Expense
SG&A Expense2.1B2.0B2.0B2.1B2.1B
General & Admin Expense
Selling & Marketing Expense
Other Expenses92.0M1.2B1.2B1.2B
Total Operating Expenses2.1B2.0B3.2B3.3B3.2B
Cost and Expenses14.7B14.0B13.2B13.0B12.6B
Operating Income (EBIT)2.3B2.3B2.2B2.0B1.8B
Non-Operating
Interest Income37.0M45.0M47.0M36.0M13.0M
Interest Expense771.0M729.0M670.0M672.0M416.0M
Net Interest Income(734.0M)(684.0M)(623.0M)(636.0M)(403.0M)
Other Non-Op Income/Expense(696.0M)(674.0M)(533.0M)(518.0M)(448.0M)
Non-Operating Income (excl Interest)(40.0M)(33.0M)(137.0M)(154.0M)20.0M
EBT (Pre-Tax Income)1.6B1.6B1.7B1.5B1.4B
Income Tax Expense253.0M252.0M296.0M101.0M260.0M
Bottom Line
Net Income1.4B1.4B1.4B1.4B1.1B
Earnings from Cont. Ops1.4B1.4B1.4B1.4B1.1B
Earnings from Discont. Ops
Bottom Line Net Income1.4B1.4B1.4B1.4B1.1B
Per Share
Basic EPS$8.13$7.91$7.57$7.39$5.82
Diluted EPS$8.06$7.84$7.49$7.29$5.72
Revenue Per Share$101.57$94.88$84.97$81.52$76.81
Shares
Basic Shares Outstanding167.2M171.9M181.3M183.8M187.6M
Diluted Shares Outstanding168.6M173.5M183.4M186.3M190.6M
Profitability Metrics
EBITDA3.5B3.5B3.5B3.3B2.9B
D&A1.2B1.1B1.1B1.1B1.1B
EBIT2.3B2.3B2.3B2.1B1.8B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026